Global Markets and Technologies for Molecular Imaging Devices

  • November 2013
  • -
  • BCC Research
  • -
  • 240 pages

STUDY GOALS AND OBJECTIVES

The objectives of this study are to present a comprehensive look at molecular imaging devices used for diagnostic purposes, present global market measurements of both the overall market and all possible market segments as well as forecast market and segment growth over the next five years.

REASONS FOR STUDY

This BCC Research study is presented to provide an in-depth market analysis of the molecular imaging device industry. The study includes an analysis of the factors driving the growth, challenges affecting the industry, and opportunities that participants can tap within the forecast period. The report also reviews the competitive landscape, leading pipeline products, pricing and technology offerings.

Key geographies covered include the U.S., Canada, the U.K., Germany, France, Italy, Spain, Japan, China, India and Australia. Key segments covered are planar scintillation cameras, PET, PET–CT, SPECT and SPECT–CT systems. This report will benefit the market participants in making more informed business decisions; in developing business strategies; in market entry and market expansion strategies; and in understanding the overall market landscape for molecular imaging devices. This report also examines the impact of reimbursement cuts and a declining overall economy on molecular imaging market progression.

SCOPE OF STUDY

This report is a comprehensive business tool designed to provide an in–depth look at molecular imaging devices for various applications. The geographic scope of the report is global, with a special emphasis on individual regions. The report describes the industry, its relationship to the healthcare industry and its participants and trends for the future.

Categories discussed in the report include:
• Planar scintillation cameras.
• PET.
• PET–CT.
• SPECT.
• SPECT–CT.

Applications discussed in the report include:
• Oncology.
• Cardio and vascular.
• Neurology.
• Others (brain imaging, tumors, Alzheimer’s, aneurysms, bone scanning, irregular or inadequate functioning of organs, myocardial perfusion imaging).

All categories are discussed in detail, describing each segment, identifying current products in the market, measuring market size, identifying market drivers, forecasting for 2013 through 2018 and assessing the competitors and competitor market shares. For country–level breakdown of segments, only the base year 2013 and projections through 2018 are shown in the data tables.

The market evaluated in this study pertains to new nuclear medicine and PET imaging systems that are developed and approved for human clinical use. The market sizing only takes into account the new equipment. Options/upgrades or refurbished/remarketed equipment have not been accounted for in the quantitative estimates and forecasts provided in the study. Ancillary products and services, including contrast agents, radiopharmaceuticals, licensing fees, cyclotrons, radiotherapy equipment, and mobile imaging devices have been excluded from the study. Also, integrated PET/MRI systems are not accounted for in forecasts pertaining to the market segment.

METHODOLOGY AND INFORMATION SOURCES

The information and analysis presented in this BCC Research report are based on primary research in the form of interviews with manufacturers, healthcare providers and thought leaders in the healthcare field. Background information was obtained from various. government agencies, business and medical journals, trade magazines, and interviews with opinion leaders, the research and development (R&D) community, product managers, marketing managers and government officials.

Key information from published literature was used to conduct interviews with more than 20 industry participants to validate and obtain expert opinions on current and future trends in the computed tomography market. Interviews were the primary basis for the development of market size. A bottom–up approach was utilized, looking at market metrics country–wise, using information at the country level to look at dynamics, and their impact on revenues and growth. Interviews were also used to confirm and/or adjust market size and market share estimates, as well as formulate market projections.

Input from primary research was applied to market data to establish the market metrics. Base year revenues were employed in conjunction with average pricing to establish unit shipments, and forecasts were established using quantitative market input, and qualitative trends that impact growth rate.

All market data pertain to the global market at the manufacturer level. Data are expressed in current U.S. dollars. The base year was 2013. Historical data are provided for 2012 and forecast data are provided for 2018. Historical, base year and forecast data are provided for each market segment and sub segment. Market shares are provided for each market segment for the 2013 base year. The mathematical model utilizes historical, base year, weighted average selling price (WASP) estimates to draw market projections. The study implements aggregate calculations and estimates and is unable to take into account the unexpected shifts in demand that result from unforeseen prices changes, regulatory changes, or sudden changes in patient and end–user characteristics.

ANALYST CREDENTIALS

Smruti Munshi is a research analyst who has specialized in the medical technologies space for the last five years. She focuses on monitoring and analyzing emerging trends, technologies, competitive benchmarking and market dynamics in the medical imaging industry. She has worked on several projects spanning the EMEA markets ranging from market insights, and industry overviews to comprehensive marketing and technology–oriented custom consulting. Ms. Munshi has an M.S. in Biomedical Engineering and a B.S. in Instrumentation and Control Engineering.

REPORT HIGHLIGHTS

The global market for molecular imaging devices was valued at $2 billion in 2012. This market is expected to reach $2.2 billion in 2013 and nearly $3 billion by 2018, with a compound annual growth rate (CAGR) of 6.2% for the period of 2013 to 2018.

This report provides:
• An overview of the global market for molecular imaging devices, which offers a new dimension to medicine as it evolves toward more personalized forms of treatment.
• Analyses of global market trends, with data from 2012, estimates for 2013, and projections of CAGRs for the period 2013 to 2018.
• Examination of factors driving growth, market figures related to the current value of molecular imaging equipment, market shares, and key players.
• Reviews of the competitive landscape, leading pipeline products, pricing, and technology offerings.
• Identification of the types of molecular imaging devices, including stand-alone planar imaging, PET, PET-CT, SPECT, and SPECT-CT.
• Comprehensive company profiles of major manufacturers.

Table Of Contents

TABLE OF CONTENTS

CHAPTER 1 INTRODUCTION 2

STUDY GOALS AND OBJECTIVES 2
REASONS FOR STUDY 2
SCOPE OF STUDY 2
METHODOLOGY AND INFORMATION SOURCES 3
ANALYST CREDENTIALS 4
RELATED BCC RESEARCH REPORTS 4
BCC RESEARCH ONLINE SERVICES 4
DISCLAIMER 4

CHAPTER 2 SUMMARY 6

SUMMARY TABLE GLOBAL MARKET FOR MOLECULAR IMAGING DEVICES, THROUGH
2018 ($ MILLIONS) 7
SUMMARY FIGURE GLOBAL MARKET FOR MOLECULAR IMAGING DEVICES,
2012-2018 ($ MILLIONS) 7

CHAPTER 3 AN INTRODUCTION TO MOLECULAR IMAGING 11

RADIOPHARMACEUTICALS 13
TABLE 1 CURRENT PROCESSORS OF MO-99 BY COUNTRY 14
AN INTRODUCTION TO MOLECULAR IMAGING DEVICES 14
POSITRON EMISSION TOMOGRAPHY (PET) 14
POSITRON EMISSION TOMOGRAPHY/COMPUTED X-RAY TOMOGRAPHY
(PET/CT) 15
SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) 15
USES AND DEMAND FOR MI DEVICES 16
Aging 16
TYPES OF MOLECULAR IMAGING DEVICES 16
TABLE 2 TYPES OF MOLECULAR IMAGING SCANNERS 17
STAND-ALONE PLANAR IMAGING 17
PET 17
PET-CT 18
SPECT 18
SPECT-CT 19
APPLICATIONS OF MOLECULAR IMAGING 19
ONCOLOGY DEMOGRAPHICS 19
TABLE 3 OVERALL CANCER RATES BY COUNTRY, 2013 20
CARDIOVASCULAR DISEASE DEMOGRAPHICS 21
TABLE 4 HEART DISEASE DEATHS BY COUNTRY, 2013 22
NEUROLOGICAL DISEASE DEMOGRAPHICS 23
RESPIRATORY DISEASE DEMOGRAPHICS 23
GLOBAL BURDEN OF DISEASES 24
TABLE 5 GLOBAL LEADING CAUSES OF DISEASE BURDEN 1990 AND 2020 25
TABLE 6 GLOBAL MAJOR CAUSES OF CANCER DEATHS ESTIMATED IN 2013 25
TABLE 7 GLOBAL POPULATION BY CONTINENT OR REGION, 2011 26
TABLE 8 WORLD POPULATION-10 MOST POPULOUS COUNTRIES, 2013 26
TABLE 9 COUNTRY RANKING POPULATION (PLUS 15 MILLION) AND DENSITY (PLUS
250 PEOPLE KM2) 27
TABLE 10 UN 2012 ESTIMATES AND MEDIUM VARIANT PROJECTIONS (MILLIONS/%) 27
TABLE 11 WORLD HISTORICAL AND PREDICTED POPULATIONS BY YEAR AND
REGION, 1500-2150 (%)* 28
PRICING ANALYSIS 29
TABLE 12 AVERAGE SELLING PRICE OF MOLECULAR IMAGING DEVICES BY TYPE,
THROUGH 2018 ($) 30

CHAPTER 4 GLOBAL MARKET SIZE AND GROWTH 32

TREND TOWARDS PERSONALIZED MEDICINE 32
TABLE 13 GLOBAL MARKET AND GROWTH BY REGION FOR MOLECULAR IMAGING
DEVICES BY REGION, THROUGH 2018 ($ MILLIONS) 34
FIGURE 1 GLOBAL MARKET AND GROWTH BY REGION FOR MOLECULAR IMAGING
DEVICES BY REGION, 2012-2018 ($ MILLIONS) 34
GROWTH BY GEOGRAPHIC REGION 35
TABLE 14 GLOBAL MARKET FOR MOLECULAR IMAGING DEVICES REVENUES BY
REGION, 2013 (%) 37
FIGURE 2 GLOBAL MARKET FOR MOLECULAR IMAGING DEVICES REVENUES BY
REGION, 2013 (%) 37
TABLE 15 GLOBAL MARKET FOR MOLECULAR IMAGING DEVICES REVENUES BY
REGION, 2018 (%) 38
FIGURE 3 GLOBAL MARKET FOR MOLECULAR IMAGING DEVICES REVENUES BY
REGION, 2018 (%) 38
GROWTH BY DEVICE TYPE 38
TABLE 16 GLOBAL REVENUES FOR MOLECULAR IMAGING DEVICES BY TYPE AT
MANUFACTURERS’ SALES LEVELS THROUGH 2018 ($ MILLIONS) 39
FIGURE 4 GLOBAL REVENUES FOR MOLECULAR IMAGING DEVICES BY TYPE AT
MANUFACTURERS' SALES LEVELS, 2012-2018 ($ MILLIONS) 39
TABLE 17 GLOBAL MOLECULAR IMAGING DEVICE MARKET BY TYPE, 2013 (%) 40
FIGURE 5 GLOBAL MOLECULAR IMAGING DEVICE MARKET BY TYPE, 2013 (%) 40
TABLE 18 GLOBAL MOLECULAR IMAGING DEVICE MARKET BY TYPE, 2018 (%) 41
FIGURE 6 GLOBAL MOLECULAR IMAGING DEVICE MARKET BY TYPE, 2018 (%) 41
GROWTH BY APPLICATION 42
ALZHEIMER'S DISEASE 42
CARDIOLOGY, ONCOLOGY AND NEUROLOGY 42
TECHNOLOGY 43
COMPETITIVE ANALYSIS 43
TABLE 19 GLOBAL MOLECULAR IMAGING DEVICE MARKET COMPETITIVE ANALYSIS,
2013 ($ MILLIONS/%) 44
FIGURE 7 GLOBAL MOLECULAR IMAGING DEVICE MARKET COMPETITIVE ANALYSIS,
2013 (%) 44

CHAPTER 5 GLOBAL MARKET BY DEVICE TYPE AND APPLICATION 46

PLANAR SCINTILLATION CAMERAS 46
TABLE 20 GLOBAL MARKET FOR PLANAR SCINTILLATION CAMERAS AT
MANUFACTURERS’ SALES LEVELS, THROUGH 2018 ($ MILLIONS/UNITS) 46
FIGURE 8 GLOBAL MARKET FOR PLANAR SCINTILLATION CAMERAS AT
MANUFACTURERS' SALES LEVELS, 2012-2018 ($ MILLIONS) 47
PET SCANNERS 47
TABLE 21 GLOBAL MARKET FOR PET SCANNERS AT MANUFACTURERS' SALES
LEVELS, THROUGH 2018 ($ MILLIONS/UNITS) 47
FIGURE 9 GLOBAL MARKET FOR PET SCANNERS AT MANUFACTURERS' SALES
LEVELS, 2012-2018 ($ MILLIONS) 47
PET/CT SCANNERS 48
TABLE 22 GLOBAL MARKET FOR PET/CT SCANNERS AT MANUFACTURERS' SALES
LEVELS, THROUGH 2018 ($ MILLIONS/UNITS) 49
FIGURE 10 GLOBAL MARKET FOR PET/CT SCANNERS AT MANUFACTURER'S SALES
LEVELS, 2012-2018 ($ MILLIONS) 49
SPECT SCANNERS 49
TABLE 23 GLOBAL MARKET FOR SPECT SCANNERS AT MANUFACTURERS' SALES
LEVELS, THROUGH 2018 ($ MILLIONS/UNITS) 50
FIGURE 11 GLOBAL MARKET FOR SPECT SCANNERS AT MANUFACTURERS' SALES
LEVELS, 2012-2018 ($ MILLIONS) 50
SPECT/CT SCANNERS 50
TABLE 24 GLOBAL MARKET FOR SPECT/CT SCANNERS, THROUGH 2018 ($
MILLIONS/UNITS) 51
FIGURE 12 GLOBAL MARKET FOR SPECT/CT SCANNERS, 2012-2018 ($ MILLIONS) 51
STAND-ALONE PET SCANNERS 51
TABLE 25 GLOBAL MARKET FOR STAND-ALONE PET SCANNERS AT
MANUFACTURERS’ SALES LEVELS, THROUGH 2018 ($ MILLIONS/UNITS) 52
FIGURE 13 GLOBAL MARKET FOR STAND-ALONE PET SCANNERS AT
MANUFACTURERS' SALES LEVELS, 2012-2018 ($ MILLIONS) 52
STAND-ALONE SPECT SCANNERS 52
TABLE 26 GLOBAL MARKET FOR STAND-ALONE SPECT SCANNERS AT
MANUFACTURERS' SALES LEVELS, THROUGH 2018 ($ MILLIONS/UNITS) 53
FIGURE 14 GLOBAL MARKET FOR STAND-ALONE SPECT SCANNERS AT
MANUFACTURERS' SALES LEVELS, 2012-2018 ($ MILLIONS) 53
THE MARKET BY APPLICATION 53
ONCOLOGY 53
CARDIOLOGY AND VASCULAR APPLICATIONS 54
NEUROLOGY 54

CHAPTER 6 INDUSTRY STRUCTURE, TECHNOLOGY TRENDS: FUSION TECHNOLOGIES AND MARKET SHARE 56

INTRODUCTION 56
MARKET DRIVERS AND MARKET RESTRAINTS 57
TABLE 27 MOLECULAR IMAGING DEVICE MARKET DRIVERS BY IMPACT, 2013
THROUGH 2018 59
TABLE 28 MOLECULAR IMAGING DEVICE MARKET RESTRAINTS BY IMPACT, 2013
THROUGH 2018 59
INDUSTRY CHALLENGES 59
TECHNOLOGY TRENDS: FUSION TECHNOLOGIES 61
HYBRID PET/MR AND SPECT/MR 65
4D-PET/MRI 65
NANOBIOTECHNOLOGY 65
CLOUD COMPUTING 66
TABLE 29 SECTRA PACS CLOUD COMPUTING PACKAGES 67
TABLE 30 MAIN CLOUD PROVIDERS 67
TABLE 31 PACS CLOUD SYSTEM PROVIDERS 68
TABLE 32 ZERO-DOWNLOAD SYSTEM PROVIDERS 70
MARKET SHARE ANALYSIS 70
INTRODUCTION 70
SIEMENS 70
GE 71
Overall Segments 71
GE Healthcare 71
PHILIPS 72
Overall Segments 72
Healthcare 72
HITACHI 73
Overall Segments 73
TABLE 33 HITACHI MARKET BY REGION ($ MILLIONS) 73
TOSHIBA CORPORATION 74
Overall Segments 74

CHAPTER 7 PATENT ANALYSIS 76

THE IMPORTANCE OF A PATENT - A HISTORY IN BRIEF 76
PATENT COOPERATION TREATY (PCT) 76
OVERVIEW OF PATENTING 77
PATENT REGULATIONS IN DIFFERENT COUNTRIES 77
EU PATENTS 77
U.S. PATENT 77
CANADIAN PATENT 78
JAPANESE PATENTS 78
First to File Patent Application Procedure 78
CHINESE PATENTS 79
INDIAN PATENTS 79
BRAZILIAN PATENTS 79
RUSSIAN PATENTS 80
AUSTRALIAN PATENTS 80
SOUTH KOREAN PATENTS 81
TAIWANESE PATENTS 81
RECENTLY AWARDED PATENTS IN MOLECULAR IMAGING 82
PATENT STATISTICS BY COMPANY FOR 2010 83
TABLE 34 MOLECULAR IMAGING DEVICES: PATENTS ISSUED IN THE U.S., 2010
(NUMBER/RANKING) 83
TABLE 35 MOLECULAR IMAGING DEVICES: PATENTS ISSUED IN CHINA, 2010
(NUMBER/RANKING) 83
PATENT STATISTICS BY COMPANY FOR 2011 83
TABLE 36 MOLECULAR IMAGING DEVICES: PATENTS ISSUED IN THE U.S., 2011
(NUMBER/RANKING) 83
TABLE 37 MOLECULAR IMAGING DEVICES: PATENTS ISSUED IN EUROPE, 2011
(NUMBER/RANKING) 84
PATENT STATISTICS BY COMPANY FOR 2012 84
TABLE 38 MOLECULAR IMAGING DEVICES: EUROPEAN PATENTS ISSUED, 2012
(NUMBER/RANKING) 84
TABLE 39 MOLECULAR IMAGING DEVICES: U.S. PATENTS ISSUED, 2012
(NUMBER/RANKING) 84
PATENTS BY YEAR AND ASSIGNEE 2010 THROUGH 2013 85
TABLE 40 NUMBER OF PATENTS BY YEAR, 2010-2013* (NUMBER) 85
TABLE 41 PET/SPECT, PET/CT, SPECT/CT SCANNER PATENTS BY ASSIGNEE,
JANUARY 2010-JUNE 2012 (NUMBER/%) 86
TABLE 42 RECENT MOLECULAR IMAGING DEVICE PATENTS GRANTED TO ASSIGNEE
BY YEAR, 2011 AND 2012 87
TABLE 43 RECENT MOLECULAR IMAGING DEVICES PATENTS GRANTED TO
ASSIGNEE BY YEAR, 2010-2013 90
TABLE 44 RECENT MOLECULAR IMAGING DEVICES PATENTS GRANTED TO
ASSIGNEE BY YEAR, 2013 92
TABLE 45 RECENT MOLECULAR IMAGING DEVICES PATENTS GRANTED TO
ASSIGNEE BY YEAR, 2010 AND 2013 93
TABLE 46 RECENT MOLECULAR IMAGING DEVICES PATENTS GRANTED TO
ASSIGNEE BY YEAR, 2010 94
TABLE 47 RECENT MOLECULAR IMAGING DEVICES PATENTS GRANTED TO
ASSIGNEE BY YEAR, 2011 95
TABLE 48 RECENT MOLECULAR IMAGING DEVICES PATENTS GRANTED TO
ASSIGNEE BY YEAR, 2012 96
TABLE 49 RECENT MOLECULAR IMAGING DEVICES PATENTS GRANTED TO
ASSIGNEE BY YEAR, 2013 97

CHAPTER 8 REGULATIONS AND REIMBURSEMENT 99

OVERVIEW 99
TABLE 50 REGULATORY AGENCIES BY COUNTRY 99
GLOBAL HARMONIZATION TASK FORCE (GHTF) 100
MEDICAL DEVICE REGULATIONS BY REGION/COUNTRY 100
EUROPEAN UNION 100
UNITED STATES 101
CANADA 101
JAPAN 102
PAL Classifications 103
CHINA 103
INDIA 104
BRAZIL 105
RUSSIA 105
AUSTRALIA 106
MEXICO 107
SOUTH KOREA 108
TAIWAN 108
REIMBURSEMENT CHALLENGES 109
OVERVIEW OF REIMBURSEMENT PROCEDURES BY REGION/COUNTRY 110
EUROPEAN UNION 110
UNITED STATES 110
CANADA 111
JAPAN 111
CHINA 112
INDIA 112
BRAZIL 113
RUSSIA 113
AUSTRALIA 113
MEXICO 114
SOUTH KOREA 114
TAIWAN 114
MOLECULAR IMAGING DEVICES REGULATIONS IN GENERAL 115
FUTURE TECHNOLOGICAL DEVELOPMENTS 115

CHAPTER 9 THE NORTH AMERICAN MARKET 117

UNITED STATES 117
UNITED STATES: ELDERLY POPULATION DEMOGRAPHICS 118
TABLE 51 OLDER POPULATION IN THE U.S. BY AGE GROUP 2000-2050 119
CANADA 119
CANADA: ELDERLY POPULATION DEMOGRAPHICS 119
TABLE 52 OLDER POPULATION IN CANADA BY AGE GROUP, 2000-2050 120
THE AMERICAS: MARKET SIZE AND GROWTH OF THE MOLECULAR IMAGING
SCANNERS MARKET 120
TABLE 53 MOLECULAR IMAGING DEVICE MARKET IN THE AMERICAS BY REGION AT
MANUFACTURERS' SALES LEVELS, THROUGH 2018 ($ MILLIONS) 121
FIGURE 15 MOLECULAR IMAGING DEVICE MARKET IN THE AMERICAS BY REGION AT
MANUFACTURERS' SALES LEVELS, 2013 ($ MILLIONS) 121
FIGURE 16 MOLECULAR IMAGING DEVICE MARKET IN THE AMERICAS BY REGION AT
MANUFACTURERS' SALES LEVELS, 2018 ($ MILLIONS) 122
TABLE 54 MOLECULAR IMAGING DEVICES BY TYPE AT MANUFACTURERS' SALES
LEVELS IN THE AMERICAS, THROUGH 2018 ($ MILLIONS) 123
FIGURE 17 MARKET FOR MOLECULAR IMAGING DEVICES BY TYPE AT
MANUFACTURERS' SALES LEVELS IN THE AMERICAS, 2012-2018 ($ MILLIONS) 123
TABLE 55 MOLECULAR IMAGING MARKET SHARE BY DEVICE TYPE IN THE
AMERICAS, 2013 (%) 124
FIGURE 18 MOLECULAR IMAGING MARKET SHARE BY DEVICE TYPE IN THE
AMERICAS, 2013 (%) 124
TABLE 56 MOLECULAR IMAGING MARKET SHARE BY DEVICE TYPE IN THE
AMERICAS, 2018 (%) 125
FIGURE 19 MOLECULAR IMAGING MARKET SHARE BY DEVICE TYPE IN THE
AMERICAS, 2018 (%) 125
TABLE 57 MARKET FOR MOLECULAR IMAGING DEVICES BY COMPANY IN THE
AMERICAS, 2013 ($ MILLIONS/%) 126
FIGURE 20 MARKET FOR MOLECULAR IMAGING DEVICES BY COMPANY IN THE
AMERICAS, 2013 (%) 126
UNITED STATES 127
TABLE 58 U.S. MARKET FOR MOLECULAR IMAGING DEVICES, THROUGH 2018 ($
MILLIONS) 128
FIGURE 21 U.S. MARKET FOR MOLECULAR IMAGING DEVICES, 2012-2018 ($
MILLIONS) 128
TABLE 59 U.S. REGIONAL BREAKDOWN BY MOLECULAR IMAGING DEVICE TYPE,
THROUGH 2018 ($ MILLIONS) 129
FIGURE 22 U.S. REGIONAL BREAKDOWN BY MOLECULAR IMAGING DEVICE TYPE,
2013 AND 2018 ($ MILLIONS) 129
CANADA 130
TABLE 60 MARKET FOR MOLECULAR IMAGING DEVICES IN CANADA, THROUGH
2018 ($ MILLIONS/UNITS) 130
FIGURE 23 MARKET FOR MOLECULAR IMAGING DEVICES IN CANADA, 2012-2018 ($
MILLIONS) 131
TABLE 61 REVENUE FOR MOLECULAR IMAGING DEVICES IN CANADA BY TYPE,
THROUGH 2018 ($ MILLIONS) 132
FIGURE 24 CANADIAN REVENUE BY MOLECULAR IMAGING DEVICE TYPE, 2013 AND
2018 ($ MILLIONS) 132

CHAPTER 10 THE EUROPEAN MARKET 135

EUROPEAN ELDERLY POPULATION DEMOGRAPHICS 136
FRANCE 137
France's Elderly Demographics 137
TABLE 62 FRANCE’S OLDER POPULATION BY AGE GROUP 2000-2050 138
GERMANY 138
Germany's Elderly Demographics 139
TABLE 63 GERMANY’S OLDER POPULATION BY AGE GROUP, 2000-2050 139
ITALY 140
Italy's Elderly Demographics 140
TABLE 64 ITALY’S OLDER POPULATION BY AGE GROUP 2000-2050 141
SPAIN 141
Spain's Elderly Demographics 142
TABLE 65 SPAIN'S OLDER POPULATION BY AGE GROUP, 2000-2050 142
UNITED KINGDOM 142
U.K.'S Elderly Demographics 143
TABLE 66 U.K.'S OLDER POPULATION BY AGE GROUP 2000-2050 143
BENELUX 144
The Netherlands Elderly Demographics 146
TABLE 67 THE NETHERLANDS' OLDER POPULATION BY AGE GROUP, 2000-2050 146
Belgium's Elderly Demographics 146
TABLE 68 BELGIUM’S OLDER POPULATION BY AGE GROUP, 2000-2050 147
Luxembourg's Elderly Demographics 147
TABLE 69 LUXEMBOURG’S OLDER POPULATION BY AGE GROUP 2000-2050 148
SCANDINAVIA 148
Denmark's Elderly Demographics 149
TABLE 70 DENMARK'S OLDER POPULATION BY AGE GROUP 2000-2050 149
Norway's Elderly Demographics 150
TABLE 71 NORWAY’S OLDER POPULATION BY AGE GROUP 2000-2050 151
Sweden's Elderly Demographics 151
TABLE 72 SWEDEN'S OLDER POPULATION BY AGE GROUP, 2000-2050 152
EUROPEAN MOLECULAR IMAGING DEVICES MARKET SIZE AND GROWTH 152
TABLE 73 MOLECULAR IMAGING DEVICE MARKET IN EUROPE BY REGION AT
MANUFACTURERS' SALES LEVELS, THROUGH 2018 ($ MILLIONS) 154
FIGURE 25 MOLECULAR IMAGING DEVICE MARKET IN EUROPE BY REGION AT
MANUFACTURERS' SALES LEVELS, 2012-2018 ($ MILLIONS) 155
TABLE 74 MOLECULAR IMAGING DEVICE MARKET IN EUROPE BY TYPE AT
MANUFACTURERS' SALES LEVELS, THROUGH 2018 ($ MILLIONS) 156
FIGURE 26 MOLECULAR IMAGING DEVICE MARKET IN EUROPE BY TYPE AT
MANUFACTURERS' SALES LEVELS, 2012-2018 ($ MILLIONS) 156
TABLE 75 MOLECULAR IMAGING DEVICE MARKET SHARE BY TYPE, 2013 (%) 157
FIGURE 27 MOLECULAR IMAGING DEVICE MARKET SHARE IN EUROPE BY TYPE,
2013 (%) 157
TABLE 76 MOLECULAR IMAGING DEVICE MARKET SHARE IN EUROPE BY TYPE, 2018
(%) 158
FIGURE 28 MOLECULAR IMAGING DEVICE MARKET SHARE BY TYPE, 2018 (%) 159
EUROPEAN MOLECULAR IMAGING DEVICE MARKET: APPLICATIONS 159
EUROPEAN MOLECULAR IMAGING DEVICE MARKET: COMPANY 159
TABLE 77 EUROPEAN MARKET FOR MOLECULAR IMAGING DEVICES BY COMPANY,
2013 (%) 160
FIGURE 29 EUROPEAN MARKET FOR MOLECULAR IMAGING DEVICES BY COMPANY,
2013 (%) 160
FRANCE 161
TABLE 78 MARKET FOR MOLECULAR IMAGING DEVICES IN FRANCE, THROUGH
2018 161
FIGURE 30 MARKET FOR MOLECULAR IMAGING DEVICES IN FRANCE, 2012-2018 ($
MILLIONS) 161
TABLE 79 MOLECULAR IMAGING DEVICES REVENUE BY TYPE IN FRANCE, THROUGH
2018 ($ MILLIONS) 162
FIGURE 31 MOLECULAR IMAGING DEVICES REVENUE BY TYPE IN FRANCE, 2013
AND 2018 ($ MILLIONS) 162
GERMANY 163
TABLE 80 MARKET FOR MOLECULAR IMAGING DEVICES IN GERMANY, THROUGH
2018 ($ MILLIONS/UNITS) 163
FIGURE 32 MARKET FOR MOLECULAR IMAGING DEVICES IN GERMANY, 2012-2018
($ MILLIONS) 163
TABLE 81 MOLECULAR IMAGING REVENUE BY DEVICE IN GERMANY, 2013 AND
2018 ($ MILLIONS) 164
FIGURE 33 MOLECULAR IMAGING REVENUE BY DEVICE IN GERMANY, 2013 AND
2018 ($ MILLIONS) 164
ITALY 165
TABLE 82 MARKET FOR MOLECULAR IMAGING DEVICES IN ITALY, THROUGH 2018
($ MILLIONS/UNITS) 165
FIGURE 34 MARKET FOR MOLECULAR IMAGING DEVICES IN ITALY, 2012-2018 ($
MILLIONS) 165
TABLE 83 MOLECULAR IMAGING REVENUE BY DEVICE IN ITALY, 2013 AND 2018 ($
MILLIONS) 166
FIGURE 35 MOLECULAR IMAGING REVENUE BY DEVICE IN ITALY, 2013 AND 2018 ($
MILLIONS) 166
SPAIN 167
TABLE 84 MARKET FOR MOLECULAR IMAGING DEVICES IN SPAIN, THROUGH 2018
($ MILLIONS/UNITS) 167
FIGURE 36 MARKET FOR MOLECULAR IMAGING DEVICES IN SPAIN, 2012-2018 ($
MILLIONS) 167
TABLE 85 MOLECULAR IMAGING REVENUE BY DEVICE TYPE IN SPAIN, THROUGH
2018 ($ MILLIONS) 168
FIGURE 37 MOLECULAR IMAGING REVENUE BY DEVICE TYPE IN SPAIN, 2013-2018
($ MILLIONS) 168
UNITED KINGDOM 169
TABLE 86 MARKET FOR MOLECULAR IMAGING DEVICES IN THE U.K., THROUGH
2018 ($ MILLIONS/UNITS) 169
FIGURE 38 MARKET FOR MOLECULAR IMAGING DEVICES IN THE U.K., 2012-2018 ($
MILLIONS) 169
TABLE 87 MOLECULAR IMAGING REVENUE BY DEVICE IN THE U.K., 2013 AND 2018
($ MILLIONS) 170
FIGURE 39 MOLECULAR IMAGING REVENUE BY DEVICE IN THE U.K., 2013 AND
2018 ($ MILLIONS) 170
SCANDINAVIA 171
TABLE 88 MARKET FOR MOLECULAR IMAGING DEVICES IN THE SCANDINAVIA
REGION, THROUGH 2018 ($ MILLIONS/UNITS) 171
FIGURE 40 MARKET FOR MOLECULAR IMAGING DEVICES IN THE SCANDINAVIA
REGION, 2012-2018 ($ MILLIONS) 171
TABLE 89 MOLECULAR IMAGING REVENUE BY DEVICE IN THE SCANDINAVIA
REGION, 2013 AND 2018 ($ MILLIONS) 172
FIGURE 41 MOLECULAR IMAGING REVENUE BY DEVICE IN THE SCANDINAVIA
REGION, 2013-2018 ($ MILLIONS) 172
BENELUX 173
TABLE 90 MARKET FOR MOLECULAR IMAGING DEVICES IN THE BENELUX REGION,
THROUGH 2018 ($ MILLIONS/UNITS) 173
FIGURE 42 MARKET FOR MOLECULAR IMAGING DEVICES IN THE BENELUX REGION,
2012-2018 ($ MILLIONS) 173
TABLE 91 MOLECULAR IMAGING REVENUE BY DEVICE IN THE BENELUX REGION,
2013 AND 2018 ($ MILLIONS) 175
FIGURE 43 MOLECULAR IMAGING REVENUE BY DEVICE IN THE BENELUX REGION,
2013 AND 2018 ($ MILLIONS) 175

CHAPTER 11 THE ASIAN MARKET 177

OVERVIEW 177
THE ASIAN MARKET 177
INDIA 178
TABLE 92 HEALTHCARE GOALS BY YEAR 179
India's Elderly Population Demographics 180
TABLE 93 INDIA'S POPULATION DEMOGRAPHIC FIGURES FOR 2013 180
TABLE 94 INDIA’S OLDER POPULATION BY AGE GROUP 2000-2050 181
JAPAN 181
Japan's Elderly Population Demographics 182
TABLE 95 JAPAN’S OLDER POPULATION BY AGE GROUP 2000-2050 182
CHINA 183
China's Elderly Population Demographics 183
TABLE 96 CHINA’S OLDER POPULATION BY AGE GROUP, 2000-2050 184
MARKET FOR MOLECULAR IMAGING SCANNERS IN ASIA 184
TABLE 97 CONTRIBUTIONS BY EMERGING ECONOMIES INTO A CENTRAL FUND ($
BILLIONS) 184
TABLE 98 MARKET FOR MOLECULAR IMAGING SCANNERS BY GEOGRAPHIC REGION
AT MANUFACTURERS’ SALES LEVELS IN ASIA, THROUGH 2018 ($ MILLIONS) 184
FIGURE 44 MARKET FOR MOLECULAR IMAGING SCANNERS BY GEOGRAPHIC
REGION AT MANUFACTURERS' SALES LEVELS IN ASIA, 2012-2018 ($ MILLIONS) 185
TABLE 99 MARKET FOR MOLECULAR IMAGING DEVICES IN ASIA BY TYPE AT
MANUFACTURERS’ SALES LEVELS, THROUGH 2018 ($ MILLIONS) 186
FIGURE 45 MARKET FOR MOLECULAR IMAGING SCANNERS BY DEVICE AT
MANUFACTURERS' SALES LEVELS IN ASIA, 2012-2018 ($ MILLIONS) 186
TABLE 100 ASIAN MOLECULAR IMAGING MARKET BY DEVICE 2013 (%) 187
FIGURE 46 ASIAN MOLECULAR IMAGING MARKET BY DEVICE TYPE 2013 (%) 187
TABLE 101 ASIAN MOLECULAR IMAGING MARKET BY DEVICE TYPE, 2018 (%) 188
FIGURE 47 ASIAN MOLECULAR IMAGING MARKET BY DEVICE TYPE, 2018 (%) 188
TABLE 102 MARKET FOR MOLECULAR IMAGING DEVICES BY COMPANY IN ASIA,
2013 ($ MILLIONS/%) 189
FIGURE 48 MARKET FOR MOLECULAR IMAGING DEVICES BY COMPANY IN ASIA,
2013 (%) 189
INDIA 190
TABLE 103 MARKET FOR MOLECULAR IMAGING DEVICES IN INDIA, THROUGH 2018
($ MILLIONS/UNITS) 190
FIGURE 49 MARKET FOR MOLECULAR IMAGING DEVICES IN INDIA, 2012-2018 ($
MILLIONS) 190
TABLE 104 REVENUE BY MOLECULAR IMAGING DEVICE IN INDIA, THROUGH 2018
($ MILLIONS) 191
FIGURE 50 REVENUE BY MOLECULAR IMAGING DEVICE IN INDIA, 2013 AND 2018 ($
MILLIONS) 191
CHINA 192
TABLE 105 MARKET FOR MOLECULAR IMAGING DEVICES IN CHINA THROUGH 2018
($ MILLIONS/UNITS) 192
FIGURE 51 MARKET FOR MOLECULAR IMAGING DEVICES IN CHINA, 2012-2018 ($
MILLIONS) 192
TABLE 106 REVENUE BY MOLECULAR IMAGING DEVICE IN CHINA, 2013 AND 2018
($ MILLIONS) 193
FIGURE 52 REVENUE FOR MOLECULAR IMAGING DEVICES IN CHINA, 2013 AND
2018 ($ MILLIONS) 193
JAPAN 193
TABLE 107 MARKET FOR MOLECULAR IMAGING DEVICES IN JAPAN, THROUGH 2018
($ MILLIONS/UNITS) 194
FIGURE 53 MARKET FOR MOLECULAR IMAGING DEVICES IN JAPAN 2012-2018 ($
MILLIONS) 194
TABLE 108 REVENUE FOR MOLECULAR IMAGING DEVICES IN JAPAN, 2013 AND
2018 ($ MILLIONS) 195
FIGURE 54 REVENUE FOR MOLECULAR IMAGING DEVICES IN JAPAN 2013 AND 2018
($ MILLIONS) 195

CHAPTER 12 EMERGING MARKETS 197

AUSTRALIA 197
AUSTRALIA'S ELDERLY POPULATION DEMOGRAPHICS 198
TABLE 109 AUSTRALIA'S OLDER POPULATION BY AGE GROUP, 2000-2050 198
BRAZIL 198
BRAZIL'S ELDERLY POPULATION DEMOGRAPHICS 199
TABLE 110 BRAZIL'S OLDER POPULATION BY AGE GROUP 2000-2050 200
ISRAEL 200
ISRAEL'S ELDERLY POPULATION DEMOGRAPHICS 201
TABLE 111 ISRAEL'S OLDER POPULATION BY AGE GROUP, 2000-2050 201
RUSSIA 201
RUSSIA'S ELDERLY POPULATION DEMOGRAPHICS 202
TABLE 112 RUSSIA’S OLDER POPULATION BY AGE GROUP, 2000-2050 203
MARKET FOR MOLECULAR IMAGING SCANNERS IN EMERGING COUNTRIES 203
TABLE 113 MARKET FOR MOLECULAR IMAGING DEVICES BY REGION AT
MANUFACTURERS' SALES LEVELS IN EMERGING MARKETS, THROUGH 2018 ($
MILLIONS)
204
FIGURE 55 MARKET FOR MOLECULAR IMAGING DEVICES BY REGION AT
MANUFACTURERS' SALES LEVELS IN EMERGING MARKETS, 2012-2018 ($ MILLIONS) 205
TABLE 114 EMERGING MOLECULAR IMAGING DEVICE MARKET BY TYPE, 2018 (%) 205
TABLE 115 MARKET FOR MOLECULAR IMAGING DEVICES BY TYPE AT
MANUFACTURERS' SALES LEVELS IN EMERGING MARKETS, THROUGH 2018 ($
MILLIONS)
206
FIGURE 56 MARKET FOR MOLECULAR IMAGING DEVICES BY TYPE AT
MANUFACTURERS' SALES LEVELS IN EMERGING MARKET 2012-2018 ($ MILLIONS) 206
TABLE 116 EMERGING MOLECULAR IMAGING DEVICE MARKET BY TYPE, 2013 (%) 207
FIGURE 57 EMERGING MOLECULAR IMAGING DEVICE MARKET BY TYPE, 2013 (%) 207
TABLE 117 MARKET FOR MOLECULAR IMAGING DEVICES IN EMERGING MARKETS
BY COMPANY, 2013 ($ MILLIONS/%) 208
FIGURE 58 MARKET FOR MOLECULAR IMAGING DEVICES IN EMERGING MARKETS
BY COMPANY, 2013 (%) 208
AUSTRALIA 209
TABLE 118 MARKET FOR MOLECULAR IMAGING DEVICES IN AUSTRALIA, THROUGH
2018 ($ MILLIONS/%) 209
FIGURE 59 MARKET FOR MOLECULAR IMAGING DEVICES IN AUSTRALIA, 2012-2018
($ MILLIONS) 209
TABLE 119 REVENUE FOR MOLECULAR IMAGING DEVICES BY TYPE IN AUSTRALIA,
THROUGH 2018 ($ MILLIONS) 210
FIGURE 60 REVENUE FOR MOLECULAR IMAGING DEVICES BY TYPE IN AUSTRALIA,
2013 AND 2018 ($ MILLIONS) 210
BRAZIL 210
TABLE 120 MARKET FOR MOLECULAR IMAGING DEVICES IN BRAZIL, THROUGH
2018 ($ MILLIONS/UNITS) 211
FIGURE 61 MARKET FOR MOLECULAR IMAGING DEVICES IN BRAZIL, 2012-2018 ($
MILLIONS) 211
TABLE 121 REVENUE FOR MOLECULAR IMAGING DEVICES IN BRAZIL, THROUGH
2018 ($ MILLIONS) 212
FIGURE 62 REVENUE FOR MOLECULAR IMAGING DEVICES IN BRAZIL, 2013 AND
2018 ($ MILLIONS) 212
ISRAEL 213
TABLE 122 MARKET FOR MOLECULAR IMAGING DEVICES IN ISRAEL, THROUGH
2018 ($ MILLIONS/UNITS) 213
FIGURE 63 MARKET FOR MOLECULAR IMAGING DEVICES IN ISRAEL, 2012-2018 ($
MILLIONS) 214
TABLE 123 REVENUE FOR MOLECULAR IMAGING DEVICES IN ISRAEL BY TYPE,
THROUGH 2018 ($ MILLIONS) 214
FIGURE 64 REVENUE FOR MOLECULAR IMAGING DEVICES IN ISRAEL BY TYPE, 2013
AND 2018 ($ MILLIONS) 215
RUSSIA 215
TABLE 124 MARKET FOR MOLECULAR IMAGING DEVICES IN RUSSIA, THROUGH
2018 ($ MILLIONS/UNITS) 216
FIGURE 65 MARKET FOR MOLECULAR IMAGING DEVICES IN RUSSIA, 2012-2018 ($
MILLIONS) 216
TABLE 125 REVENUE FOR MOLECULAR IMAGING DEVICES IN RUSSIA BY TYPE,
THROUGH 2018 ($ MILLIONS) 217
FIGURE 66 REVENUE FOR MOLECULAR IMAGING DEVICES IN RUSSIA BY TYPE, 2013
AND 2018 ($ MILLIONS) 217

CHAPTER 13 MARKET STRATEGIES STRATEGIC RECOMMENDATIONS 220

SUGGESTED STRATEGIES - A GENERAL OVERVIEW 220
EMPLOY A MARKETING COMPANY 220
INCREASED EXPOSURE 220
COMPETITIVE DEVICES AND PRICING 221
TABLE 126 HEALTHCARE SERVICES, COMPARED BY COUNTRY 221
RandD - PATIENT POWER 222
PATENTING STRATEGIES 222
ADDRESSING THE PRIMARY CONCERNS 223
PRIMARY CONCERNS: 223
Primary Concerns: Numbers 1 through 5: 223
Primary Concerns: Numbers 6 through 8 225
Mobile Units 226
Primary Concerns: Numbers 9 and 10 226
TABLE 127 AVERAGE DOSE MDP-SPECT 227
TABLE 128 AVERAGE DOSE FDG-PET 228
Primary Concern: Number 11 228
Primary Concern: Number 12 229
Primary Concern: Number 13 230

CHAPTER 14 COMPANY PROFILES 233

MOLECULAR IMAGING OVERVIEW 233
MARKET DRIVERS 233
CHALLENGES 233
A REVIEW OF INDIVIDUAL COMPANIES 234
CARDIARC 234
Overview 234
Highlights 235
Segments 235
Products 235
DIGIRAD 235
Overview 235
Highlights 235
Segments 235
Products 236
DILON DIAGNOSTICS 236
Overview 236
Highlights 236
Segments 236
Products 236
GAMMA MEDICA INC. 237
Overview 237
Highlights 237
Segments 237
Products 237
GE HEALTHCARE 237
Overview 238
Highlights 238
Segments 238
Products 238
GVI MEDICAL DEVICES 239
Overview 239
Highlights 239
Segments 239
Products 239
HITACHI MEDICAL SYSTEMS 239
Overview 239
Highlights 240
Segments 240
Products 240
MEDISO IMAGING SYSTEMS 240
Overview 240
Highlights 241
Segments 241
Products 241
NAVISCAN 241
Overview 241
Highlights 242
Segments 242
Products 242
NEUROLOGICA CORPORATION 242
Overview 242
Highlights 242
Segments 243
Products 243
NEUSOFT MEDICAL LTD 243
Overview 243
Highlights 243
Segments 243
Products 244
NUCLEAR CARDIOLOGY SYSTEMS 244
Overview 244
Highlights 244
Segments 244
Products 245
PHILIPS MEDICAL SYSTEMS 245
Overview 245
Highlights 245
TABLE 129 PHILIPS MEDICAL SYSTEMS AWARDS 246
Segments 246
Products 246
POSITRON CORPORATION 246
Overview 246
Highlights 247
Segments 247
Products 247
SIEMENS HEALTHCARE 247
Overview 248
Highlights 248
Segments 248
Products 248
SPECTRUM DYNAMICS 248
Overview 249
Highlights 249
Segments 249
Products 249
TOSHIBA MEDICAL SYSTEMS 249
Overview 249
TABLE 130 GOVERNMENT ANNUAL CONTRACTS AWARDED 250
Highlights 250
Segments 250
Products 250
TRIVITRON HEALTHCARE 250
Overview 251
Highlights 251
Segments 251
Products 251
ACQUISITIONS AND ALLIANCES 252
TABLE 131 NEUSOFT MEDICAL STRATEGIC ACQUISITIONS AND ALLIANCES, 2012 252
TABLE 132 GE HEALTHCARE STRATEGIC ACQUISITIONS AND ALLIANCES 1998-2012 252
TABLE 133 NEUROLOGICA CORP STRATEGIC ACQUISITIONS AND ALLIANCES, 2012 253
TABLE 134 PHILIPS HEALTHCARE STRATEGIC ACQUISITIONS AND ALLIANCES,
1998-2012 253
TABLE 135 SIEMENS HEALTHCARE STRATEGIC ACQUISITIONS AND ALLIANCES
2006 AND 2007 253
TABLE 136 TOSHIBA MEDICAL SYSTEMS STRATEGIC ACQUISITIONS AND ALLIANCES,
2003-2009 254
TABLE 137 TRIVITRON HEALTHCARE STRATEGIC ACQUISITIONS AND ALLIANCES,
1998-2012 254



LIST OF TABLES

SUMMARY TABLE GLOBAL MARKET FOR MOLECULAR IMAGING DEVICES, THROUGH
2018 ($ MILLIONS) 7
TABLE 1 CURRENT PROCESSORS OF MO-99 BY COUNTRY 14
TABLE 2 TYPES OF MOLECULAR IMAGING SCANNERS 17
TABLE 3 OVERALL CANCER RATES BY COUNTRY, 2013 20
TABLE 4 HEART DISEASE DEATHS BY COUNTRY, 2013 22
TABLE 5 GLOBAL LEADING CAUSES OF DISEASE BURDEN 1990 AND 2020 25
TABLE 6 GLOBAL MAJOR CAUSES OF CANCER DEATHS ESTIMATED IN 2013 25
TABLE 7 GLOBAL POPULATION BY CONTINENT OR REGION, 2011 26
TABLE 8 WORLD POPULATION-10 MOST POPULOUS COUNTRIES, 2013 26
TABLE 9 COUNTRY RANKING POPULATION (PLUS 15 MILLION) AND DENSITY (PLUS
250 PEOPLE KM2) 27
TABLE 10 UN 2012 ESTIMATES AND MEDIUM VARIANT PROJECTIONS (MILLIONS/%) 27
TABLE 11 WORLD HISTORICAL AND PREDICTED POPULATIONS BY YEAR AND REGION,
1500-2150 (%)* 28
TABLE 12 AVERAGE SELLING PRICE OF MOLECULAR IMAGING DEVICES BY TYPE,
THROUGH 2018 ($) 30
TABLE 13 GLOBAL MARKET AND GROWTH BY REGION FOR MOLECULAR IMAGING
DEVICES BY REGION, THROUGH 2018 ($ MILLIONS) 34
TABLE 14 GLOBAL MARKET FOR MOLECULAR IMAGING DEVICES REVENUES BY
REGION, 2013 (%) 37
TABLE 15 GLOBAL MARKET FOR MOLECULAR IMAGING DEVICES REVENUES BY
REGION, 2018 (%) 38
TABLE 16 GLOBAL REVENUES FOR MOLECULAR IMAGING DEVICES BY TYPE AT
MANUFACTURERS’ SALES LEVELS THROUGH 2018 ($ MILLIONS) 39
TABLE 17 GLOBAL MOLECULAR IMAGING DEVICE MARKET BY TYPE, 2013 (%) 40
TABLE 18 GLOBAL MOLECULAR IMAGING DEVICE MARKET BY TYPE, 2018 (%) 41
TABLE 19 GLOBAL MOLECULAR IMAGING DEVICE MARKET COMPETITIVE ANALYSIS,
2013 ($ MILLIONS/%) 44
TABLE 20 GLOBAL MARKET FOR PLANAR SCINTILLATION CAMERAS AT
MANUFACTURERS’ SALES LEVELS, THROUGH 2018 ($ MILLIONS/UNITS) 46
TABLE 21 GLOBAL MARKET FOR PET SCANNERS AT MANUFACTURERS' SALES
LEVELS, THROUGH 2018 ($ MILLIONS/UNITS) 47
TABLE 22 GLOBAL MARKET FOR PET/CT SCANNERS AT MANUFACTURERS' SALES
LEVELS, THROUGH 2018 ($ MILLIONS/UNITS) 49
TABLE 23 GLOBAL MARKET FOR SPECT SCANNERS AT MANUFACTURERS' SALES
LEVELS, THROUGH 2018 ($ MILLIONS/UNITS) 50
TABLE 24 GLOBAL MARKET FOR SPECT/CT SCANNERS, THROUGH 2018 ($
MILLIONS/UNITS) 51
TABLE 25 GLOBAL MARKET FOR STAND-ALONE PET SCANNERS AT
MANUFACTURERS’ SALES LEVELS, THROUGH 2018 ($ MILLIONS/UNITS) 52
TABLE 26 GLOBAL MARKET FOR STAND-ALONE SPECT SCANNERS AT
MANUFACTURERS' SALES LEVELS, THROUGH 2018 ($ MILLIONS/UNITS) 53
TABLE 27 MOLECULAR IMAGING DEVICE MARKET DRIVERS BY IMPACT, 2013
THROUGH 2018 59
TABLE 28 MOLECULAR IMAGING DEVICE MARKET RESTRAINTS BY IMPACT, 2013
THROUGH 2018 59
TABLE 29 SECTRA PACS CLOUD COMPUTING PACKAGES 67
TABLE 30 MAIN CLOUD PROVIDERS 67
TABLE 31 PACS CLOUD SYSTEM PROVIDERS 68
TABLE 32 ZERO-DOWNLOAD SYSTEM PROVIDERS 70
TABLE 33 HITACHI MARKET BY REGION ($ MILLIONS) 73
TABLE 34 MOLECULAR IMAGING DEVICES: PATENTS ISSUED IN THE U.S., 2010
(NUMBER/RANKING) 83
TABLE 35 MOLECULAR IMAGING DEVICES: PATENTS ISSUED IN CHINA, 2010
(NUMBER/RANKING) 83
TABLE 36 MOLECULAR IMAGING DEVICES: PATENTS ISSUED IN THE U.S., 2011
(NUMBER/RANKING) 83
TABLE 37 MOLECULAR IMAGING DEVICES: PATENTS ISSUED IN EUROPE, 2011
(NUMBER/RANKING) 84
TABLE 38 MOLECULAR IMAGING DEVICES: EUROPEAN PATENTS ISSUED, 2012
(NUMBER/RANKING) 84
TABLE 39 MOLECULAR IMAGING DEVICES: U.S. PATENTS ISSUED, 2012
(NUMBER/RANKING) 84
TABLE 40 NUMBER OF PATENTS BY YEAR, 2010-2013* (NUMBER) 85
TABLE 41 PET/SPECT, PET/CT, SPECT/CT SCANNER PATENTS BY ASSIGNEE, JANUARY
2010-JUNE 2012 (NUMBER/%) 86
TABLE 42 RECENT MOLECULAR IMAGING DEVICE PATENTS GRANTED TO ASSIGNEE
BY YEAR, 2011 AND 2012 87
TABLE 43 RECENT MOLECULAR IMAGING DEVICES PATENTS GRANTED TO ASSIGNEE
BY YEAR, 2010-2013 90
TABLE 44 RECENT MOLECULAR IMAGING DEVICES PATENTS GRANTED TO ASSIGNEE
BY YEAR, 2013 92
TABLE 45 RECENT MOLECULAR IMAGING DEVICES PATENTS GRANTED TO ASSIGNEE
BY YEAR, 2010 AND 2013 93
TABLE 46 RECENT MOLECULAR IMAGING DEVICES PATENTS GRANTED TO ASSIGNEE
BY YEAR, 2010 94
TABLE 47 RECENT MOLECULAR IMAGING DEVICES PATENTS GRANTED TO ASSIGNEE
BY YEAR, 2011 95
TABLE 48 RECENT MOLECULAR IMAGING DEVICES PATENTS GRANTED TO ASSIGNEE
BY YEAR, 2012 96
TABLE 49 RECENT MOLECULAR IMAGING DEVICES PATENTS GRANTED TO ASSIGNEE
BY YEAR, 2013 97
TABLE 50 REGULATORY AGENCIES BY COUNTRY 99
TABLE 51 OLDER POPULATION IN THE U.S. BY AGE GROUP 2000-2050 119
TABLE 52 OLDER POPULATION IN CANADA BY AGE GROUP, 2000-2050 120
TABLE 53 MOLECULAR IMAGING DEVICE MARKET IN THE AMERICAS BY REGION AT
MANUFACTURERS' SALES LEVELS, THROUGH 2018 ($ MILLIONS) 121
TABLE 54 MOLECULAR IMAGING DEVICES BY TYPE AT MANUFACTURERS' SALES
LEVELS IN THE AMERICAS, THROUGH 2018 ($ MILLIONS) 123
TABLE 55 MOLECULAR IMAGING MARKET SHARE BY DEVICE TYPE IN THE AMERICAS,
2013 (%) 124
TABLE 56 MOLECULAR IMAGING MARKET SHARE BY DEVICE TYPE IN THE AMERICAS,
2018 (%) 125
TABLE 57 MARKET FOR MOLECULAR IMAGING DEVICES BY COMPANY IN THE
AMERICAS, 2013 ($ MILLIONS/%) 126
TABLE 58 U.S. MARKET FOR MOLECULAR IMAGING DEVICES, THROUGH 2018 ($
MILLIONS) 128
TABLE 59 U.S. REGIONAL BREAKDOWN BY MOLECULAR IMAGING DEVICE TYPE,
THROUGH 2018 ($ MILLIONS) 129
TABLE 60 MARKET FOR MOLECULAR IMAGING DEVICES IN CANADA, THROUGH 2018
($ MILLIONS/UNITS) 130
TABLE 61 REVENUE FOR MOLECULAR IMAGING DEVICES IN CANADA BY TYPE,
THROUGH 2018 ($ MILLIONS) 132
TABLE 62 FRANCE’S OLDER POPULATION BY AGE GROUP 2000-2050 138
TABLE 63 GERMANY’S OLDER POPULATION BY AGE GROUP, 2000-2050 139
TABLE 64 ITALY’S OLDER POPULATION BY AGE GROUP 2000-2050 141
TABLE 65 SPAIN'S OLDER POPULATION BY AGE GROUP, 2000-2050 142
TABLE 66 U.K.'S OLDER POPULATION BY AGE GROUP 2000-2050 143
TABLE 67 THE NETHERLANDS' OLDER POPULATION BY AGE GROUP, 2000-2050 146
TABLE 68 BELGIUM’S OLDER POPULATION BY AGE GROUP, 2000-2050 147
TABLE 69 LUXEMBOURG’S OLDER POPULATION BY AGE GROUP 2000-2050 148
TABLE 70 DENMARK'S OLDER POPULATION BY AGE GROUP 2000-2050 149
TABLE 71 NORWAY’S OLDER POPULATION BY AGE GROUP 2000-2050 151
TABLE 72 SWEDEN'S OLDER POPULATION BY AGE GROUP, 2000-2050 152
TABLE 73 MOLECULAR IMAGING DEVICE MARKET IN EUROPE BY REGION AT
MANUFACTURERS' SALES LEVELS, THROUGH 2018 ($ MILLIONS) 154
TABLE 74 MOLECULAR IMAGING DEVICE MARKET IN EUROPE BY TYPE AT
MANUFACTURERS' SALES LEVELS, THROUGH 2018 ($ MILLIONS) 156
TABLE 75 MOLECULAR IMAGING DEVICE MARKET SHARE BY TYPE, 2013 (%) 157
TABLE 76 MOLECULAR IMAGING DEVICE MARKET SHARE IN EUROPE BY TYPE, 2018
(%) 158
TABLE 77 EUROPEAN MARKET FOR MOLECULAR IMAGING DEVICES BY COMPANY,
2013 (%) 160
TABLE 78 MARKET FOR MOLECULAR IMAGING DEVICES IN FRANCE, THROUGH 2018 161
TABLE 79 MOLECULAR IMAGING DEVICES REVENUE BY TYPE IN FRANCE, THROUGH
2018 ($ MILLIONS) 162
TABLE 80 MARKET FOR MOLECULAR IMAGING DEVICES IN GERMANY, THROUGH
2018 ($ MILLIONS/UNITS) 163
TABLE 81 MOLECULAR IMAGING REVENUE BY DEVICE IN GERMANY, 2013 AND 2018
($ MILLIONS) 164
TABLE 82 MARKET FOR MOLECULAR IMAGING DEVICES IN ITALY, THROUGH 2018 ($
MILLIONS/UNITS) 165
TABLE 83 MOLECULAR IMAGING REVENUE BY DEVICE IN ITALY, 2013 AND 2018 ($
MILLIONS) 166
TABLE 84 MARKET FOR MOLECULAR IMAGING DEVICES IN SPAIN, THROUGH 2018 ($
MILLIONS/UNITS) 167
TABLE 85 MOLECULAR IMAGING REVENUE BY DEVICE TYPE IN SPAIN, THROUGH
2018 ($ MILLIONS) 168
TABLE 86 MARKET FOR MOLECULAR IMAGING DEVICES IN THE U.K., THROUGH 2018
($ MILLIONS/UNITS) 169
TABLE 87 MOLECULAR IMAGING REVENUE BY DEVICE IN THE U.K., 2013 AND 2018
($ MILLIONS) 170
TABLE 88 MARKET FOR MOLECULAR IMAGING DEVICES IN THE SCANDINAVIA
REGION, THROUGH 2018 ($ MILLIONS/UNITS) 171
TABLE 89 MOLECULAR IMAGING REVENUE BY DEVICE IN THE SCANDINAVIA REGION,
2013 AND 2018 ($ MILLIONS) 172
TABLE 90 MARKET FOR MOLECULAR IMAGING DEVICES IN THE BENELUX REGION,
THROUGH 2018 ($ MILLIONS/UNITS) 173
TABLE 91 MOLECULAR IMAGING REVENUE BY DEVICE IN THE BENELUX REGION,
2013 AND 2018 ($ MILLIONS) 175
TABLE 92 HEALTHCARE GOALS BY YEAR 179
TABLE 93 INDIA'S POPULATION DEMOGRAPHIC FIGURES FOR 2013 180
TABLE 94 INDIA’S OLDER POPULATION BY AGE GROUP 2000-2050 181
TABLE 95 JAPAN’S OLDER POPULATION BY AGE GROUP 2

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

The 2014 World%s Leading Diagnostic Imaging Companies

The 2014 World%s Leading Diagnostic Imaging Companies

  • $ 14 500
  • Industry report
  • August 2014
  • by Venture Planning Group

Complete report $14,500.  Individual company assessments $2,450.  The report is available by company, section, market segment, and can be custom-tailored to your specific information needs and budget. ...

Future Horizons and Growth Strategies in the Global Diagnostic Imaging Market 2014: Strategic Assessments of Leading Suppliers

Future Horizons and Growth Strategies in the Global Diagnostic Imaging Market 2014: Strategic Assessments of Leading Suppliers

  • $ 14 500
  • Industry report
  • August 2014
  • by Venture Planning Group

Complete report $14,500.  Individual company assessments $2,450.  The report is available by company, section, market segment, and can be custom-tailored to your specific information needs and budget. ...

The 2014 Global Ultrasound Market: Strategic Assessments of Leading Suppliers

The 2014 Global Ultrasound Market: Strategic Assessments of Leading Suppliers

  • $ 12 500
  • Industry report
  • August 2014
  • by Venture Planning Group

Complete report $12,500.  Individual company assessments $1,850.  The report is available by company, section, market segment, and can be custom-tailored to your specific information needs and budget. ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.